#RareDiseaseDay2025

#RareDiseaseDay2025

Happy 2025! We hope the new year is off to a good start for all our families. As mentioned in our last newsletter, the APS Type 1 Foundation will be sharing a number of resources leading up to Rare Disease Day on February 28th. Rare Disease Day (video link) is celebrated worldwide to raise awareness…

Read More

IT’S NOT TOO LATE TO GIVE

We are deeply grateful for the incredible generosity shown this Giving Tuesday, with over 60 individuals coming together to make a meaningful impact through their contributions.  Giving Tuesday may have passed, but there’s still time to participate in the giving season. You might be thinking, “I have no idea what to do.” Don’t worry—you’re in…

Read More

INDO-US BRIDGING RARE SUMMIT MEETS IN DELHI, INDIA

Representing the APS Type 1 Foundation, Board Member Pushpa Rao exhibited a poster on APS Type 1 at the Indo-US Bridging Rare Summit in Delhi, India, seeking to expand the network, include more patients of Indian origin in our APS Type 1 (APECED) Registry, and inspire research that benefits all. Over two and a half…

Read More

RARE DISEASE DAY 2025: FRIDAY, FEBRUARY 28

APS Type 1 is considered a “rare disease” because it affects fewer than 1 in 2,000 people. However, with over 6,000 conditions meeting this definition, rare diseases are anything but rare. Rare Disease Day provides a yearly opportunity to raise awareness of the 300 million people worldwide living with rare diseases. Learn more about specific…

Read More
AN ANNIVERSARY CELEBRATION IN SUPPORT OF THE APS TYPE 1 FOUNDATION

AN ANNIVERSARY CELEBRATION IN SUPPORT OF THE APS TYPE 1 FOUNDATION

Congratulations to Kevin and Jamie on their 30th wedding anniversary. This milestone is not just a celebration of their enduring love and partnership but also a testament to their commitment to making a difference in the lives of others. In lieu of traditional gifts, Kevin and Jamie chose to channel their celebration into a cause…

Read More
THE POWER OF MANY

THE POWER OF MANY

You have the power to make a significant impact on the future of the APS Type 1 community by engaging with the networks of family, friends, employers, coworkers, and community members around you. Today, we are celebrating four stories that we hope will inspire you to harness the collective power of many. READ MORE

Read More
DAVE’S RESEARCH CORNER: BACK TO SCHOOL

DAVE’S RESEARCH CORNER: BACK TO SCHOOL

As many in our community return to school or start a new academic year, it is important for students and their families to be well-prepared. This is especially crucial for those transitioning into elementary school, middle or junior high, high school, or college. To support a smooth and successful school year for individuals with APS…

Read More
WELCOME OUR NEWEST BOARD MEMBER

WELCOME OUR NEWEST BOARD MEMBER

We are pleased to announce that Gaby Talarico has joined our board, adding another valuable patient voice to guide and inform our work. Now approaching 30 years old, Gaby was diagnosed with APS Type 1 at the age of 11 and was the first participant in the Natural History Study at the National Institutes of…

Read More
OUR SINCERE GRATITUDE TO HEATHER TALARICO FOR HER YEARS OF SERVICE

OUR SINCERE GRATITUDE TO HEATHER TALARICO FOR HER YEARS OF SERVICE

As Heather Talarico retires from our board of directors, the APS Type 1 Foundation extends its heartfelt gratitude to Heather for her dedicated service to our community over many years. As a co-founder of the Foundation, Heather has been a driving force behind our success. Her relentless efforts, including a decade of organizing the Driving…

Read More
Mark Anderson Named 2024 Recipient of the prestigious Coley Award  

Mark Anderson Named 2024 Recipient of the prestigious Coley Award  

Diabetes Center Director, UCSF, Mark Anderson MD PhD has been awarded the prestigious Coley Award from the Cancer Research Institute. The Coley Award honors groundbreaking contributions to cancer research, validating and highlighting the impact of innovative work, particularly in immunotherapy and recognizes Dr. Anderson’s foundational contributions to the understanding of immune tolerance mechanisms, self-antigen presentation,…

Read More